HRAS and head and neck cancer: We confirmed previous observations that laryngeal and pharyngeal cancers rarely harbor CASP8 and HRAS mutations in comparison to oral cancers (15) – in our comparison, these alterations were almost completely absent in hypopharyngeal tumors when juxtaposed with other head and neck cancer subtypes.